Here, we report that TLR2 is expressed in both HNSCC cell lines and primary patient-derived xenografts and using a yeast-derived agonist, zymosan, we demonstrate that this receptor is functional. This evidence concerns the gene TLR2 and head and neck squamous cell carcinoma.